comprehensive -WSS

comprehensive

author：entertainment 2025-09-06 02:05:56 - browse：37499

Robert F. Kennedy Jr. arrives in the lobby of Trump Tower in New York for a meeting with President-elect Donald Trump. Evan Vucci/AP

WASHINGTON — Outspoken vaccine critic Robert Kennedy Jr. said Tuesday that he had accepted a position in Donald Trump’s administration as chair of a panel on vaccine safety and scientific integrity, in what would be the clearest sign yet of the president-elect’s suspicions about vaccines.

Kennedy’s remarks followed his meeting with the president-elect at Trump Tower and immediately sparked outrage from scientists, pediatricians, and public health experts, who fear the incoming administration could give legitimacy to skeptics of childhood immunizations despite a huge body of scientific research demonstrating that vaccines are safe. Many of those skeptics believe vaccines are a cause of autism.

Hours later, Trump spokeswoman Hope Hicks said in a statement that the president-elect was “exploring the possibility of forming a commission on Autism,” but said “no decisions have been made at this time.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Problems with a popular proposal to regulate AI in health care

hotspot

focus

WSS

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

The Biogen Aduhelm mess could happen again

A single Democrat is willing to weaken Medicare negotiation power

International team creates first chimeric human

ALS groups 'won't be played again' by the FDA, drug sponsors

Scientists unlock the key to scar

hotspot

comprehensive

focus

Drug repurposing or repositioning? The language matters

AstraZeneca loses challenge to Medicare drug price negotiation

Jerome Adams on the need for new antivirals for Covid

Medical device lobby: We're tired of waiting on Medicare coverage

Activists slam private health insurers over coverage restrictions

FDA does about

At least 13 dead in Texas as scorching temps continue

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

The cancer drug shortage isn’t new — and neither are the solutions

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Wikipedia

Devoted Health’s losses in Medicare Advantage persist

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Updated Covid vaccine has 54% effectiveness, new study suggests

Unique patient identifier: Experts argue the benefits, pitfalls

What’s missing from the debate over nursing home staff minimums

focus

hotspot

focus

explore